Skip to main content

Table 2 Medications considered in estimation of costs for treatment for high blood pressure, hypercholesterolemia, and diabetes

From: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy

  

Cost per day (SCR)

 

Dose per day

2004

2005

Daily dose and cost of medications

   

Metformin

1.5 g

4.83

0.48

Glibenclamide

10 mg

1.22

0.18

Insulin (2004:standard; 2005: pen)

20 units

3.40

7.72

Rosuvastatin (2004: Atorvastatin)

10 mg

7.81

7.31

Bendrofluazide (D)

2.5 mg

0.04

0.05

Atenolol (BB)

50 mg

0.67

0.21

Amlodipin (CCB)

5 mg

2.74

0.51

Lisinopril (ACEI)

20 mg

4.00

1.89

Valsartan (ARB)

80 mg

8.50

5.82

Combinations for treatment of hypertension (mono-, bi-, tri- or quadri-therapy)

   

D in 80% of cases or any of (BB, CCB or ACEI/ARB) in 20% of cases

Mono

0.52

0.21

D + any of (BB or CCB or ACEI/ARB)

Bi

2.51

0.92

D + BB + any of (CCB +ACEI/ARB)

Tri

4.08

1.46

D + BB +CCB + (ACEI/ARB)

Quadri

7.45

2.66

Average cost of Lisinopril in 90% cases or Valsartan in 10% of cases (ACEI/ARB)

 

4.45

2.28

Average cost of either BB or CCB or ACEI/ARB

 

2.47

0.87

Average cost of either CCB or ACEI/ARB

 

3.37

1.20

  1. US$1 ~ SCR5